Research ArticleOriginal Research
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman and Christopher R. Frei
The Journal of the American Board of Family
Medicine September 2013, 26 (5) 508-517; DOI: https://doi.org/10.3122/jabfm.2013.05.120247
Matthew J. Labreche
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Grace C. Lee
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Russell T. Attridge
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Eric M. Mortensen
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Jim Koeller
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Liem C. Du
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Natalie R. Nyren
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Lucina B. Treviño
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Sylvia B. Treviño
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Joel Peña
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Michael W. Mann
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Abilio Muñoz
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Yolanda Marcos
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Guillermo Rocha
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Stella Koretsky
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Sandra Esparza
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Mitchell Finnie
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Steven D. Dallas
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Michael L. Parchman
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
Christopher R. Frei
the Division of Pharmacotherapy, College of Pharmacy, University of Texas at Austin, Austin (MJL, GCL, JK, CRF); the Pharmacotherapy Education and Research Center, School of Medicine (MJL, GCL, JK, CRF); the South Texas Ambulatory Research Network (LCD, NRN, LBT, SBT, JP, MWM, AM, YM, GR, SK, SE, MF); the School of Health Professions, Clinical Laboratory Sciences (SDD), University of Texas Health Science Center, San Antonio; the Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX (RTA); the Division of General Internal Medicine, VA North Texas Health Care System, Dallas (EMM); the Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas (EMM); and the MacColl Center for Health Care Innovation, Group Health Research Institute, Group Health Cooperative, Seattle, WA (MLP).
References
- 1.↵
- Klevens RM,
- Morrison MA,
- Nadle J,
- et al
- 2.↵
- Klevens RM,
- Edwards JR,
- Tenover FC,
- McDonald LC,
- Horan T,
- Gaynes R
- 3.↵
- 4.↵
- Moran GJ,
- Krishnadasan A,
- Gorwitz RJ,
- et al
- 5.↵
- Frei CR,
- Miller ML,
- Lewis JS 2nd.,
- et al
- 6.↵
- Parchman ML,
- Munoz A
- 7.↵
- Stevens DL,
- Bisno AL,
- Chambers HF,
- et al
- 8.↵
- Liu C,
- Bayer A,
- Cosgrove SE,
- et al
- 9.↵
- Fridkin SK,
- Hageman JC,
- Morrison M,
- et al
- 10.↵
- 11.↵
- 12.↵
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: uncomplicated and complicated skin and skin structure infections—developing antimicrobial drugs for treatment. July 1998. Available from: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3997B1_02_GFI-Diabetic%20Foot.pdf. Accessed February 9, 2012.
- 13.↵
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: acute bacterial skin and skin structure infections—developing antimicrobial drugs for treatment. Draft guidance. August 2010. Available from: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM071185.pdf. Accessed February 9, 2012.
- 14.↵
- Corey GR,
- Stryjewski ME
- 15.↵
- Levy BT,
- Daly J
- 16.↵
- Forcade NA,
- Parchman ML,
- Jorgensen JH,
- et al
- 17.↵
- Merrill CT,
- Elixhauser A
- 18.↵
- Machlin SR
- 19.↵
- Machlin SR,
- Carper K
- 20.↵
- Russo CA,
- Owens P,
- Steiner C,
- Josephsen J
- 21.↵
US Department of Labor, Bureau of Labor Statistics. Archived Consumer Price Index detailed report information. Available from: www.bls.gov/cpi/cpi_dr.htm. Accessed November 16, 2011.
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- Davis SL,
- Delgado G Jr.,
- McKinnon PS
- 27.↵
- Kuti JL,
- Le TN,
- Nightingale CH,
- Nicolau DP,
- Quintiliani R
- 28.↵
- Ramirez JA,
- Bordon J
- 29.↵
- Mertz D,
- Koller M,
- Haller P,
- et al
- 30.↵
- Lee MC,
- Rios AM,
- Aten MF,
- et al
- 31.↵
- Frazee BW,
- Lynn J,
- Charlebois ED,
- Lambert L,
- Lowery D,
- Perdreau-Remington F
- 32.↵
- 33.↵
- Pallin DJ,
- Egan DJ,
- Pelletier AJ,
- Espinola JA,
- Hooper DC,
- Camargo CA Jr.
- 34.
Alabama Medicaid Agency Average Acquisition Cost (AAC) rate listing for generic drugs: rates effective as of November 9, 2011. Available from: http://al.mslc.com/AACList.aspx. Accessed December 1, 2011.
In this issue
The Journal of the American Board of Family
Medicine
Vol. 26, Issue 5
September-October 2013
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman, Christopher R. Frei
The Journal of the American Board of Family
Medicine Sep 2013, 26 (5) 508-517; DOI: 10.3122/jabfm.2013.05.120247
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche, Grace C. Lee, Russell T. Attridge, Eric M. Mortensen, Jim Koeller, Liem C. Du, Natalie R. Nyren, Lucina B. Treviño, Sylvia B. Treviño, Joel Peña, Michael W. Mann, Abilio Muñoz, Yolanda Marcos, Guillermo Rocha, Stella Koretsky, Sandra Esparza, Mitchell Finnie, Steven D. Dallas, Michael L. Parchman, Christopher R. Frei
The Journal of the American Board of Family
Medicine Sep 2013, 26 (5) 508-517; DOI: 10.3122/jabfm.2013.05.120247
Jump to section
Related Articles
- No related articles found.
Cited By...
- Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections
- Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections
- Transmission and Microevolution of USA300 MRSA in U.S. Households: Evidence from Whole-Genome Sequencing
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model
- Content Usage and the Most Frequently Read Articles by Issue in 2013
- Patient-Centered Research Happens in Practice-based Research Networks